Data from large clinical trials were used to determine the frequency of adverse reactions. The following convention has been used for the classification of frequency: Very common ≥1/10, Common ≥1/100 and <1/10, Uncommon ≥1/1,000 and <1/100, Rare ≥1/10,000 and <1/1,000, Very rare <1/10,000.
Clinical trial data: (See Table 2.)
Click on icon to see table/diagram/image
Post-marketing data: (See Table 3.)
Click on icon to see table/diagram/image